These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8669815)

  • 1. IL-12-mediated activation of MHC-unrestricted cytotoxicity of human PBMC subpopulations: synergic action of a plant rhamnogalacturonan.
    Klein-Franke A; Anderer FA
    Anticancer Res; 1995; 15(6B):2511-6. PubMed ID: 8669815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of NK-like activity in T cells by IL-2/anti-CD3 is linked to expression of a new antitumour receptor with specificity for acetylated mannose.
    Zollner TM; Zhu HG; Anderer FA
    Anticancer Res; 1993; 13(4):923-30. PubMed ID: 8352560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of MHC-unrestricted cytotoxic activity of human CD56+ CD3- natural killer (NK) cells and CD3+ T cells by rhamnogalacturonan: target cell specificity and activity against NK-insensitive targets.
    Zhu HG; Zollner TM; Klein-Franke A; Anderer FA
    J Cancer Res Clin Oncol; 1994; 120(7):383-8. PubMed ID: 7514604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a recombinant lectin, Viscum album agglutinin on the secretion of interleukin-12 in cultured human peripheral blood mononuclear cells and on NK-cell-mediated cytotoxicity of rat splenocytes in vitro and in vivo.
    Hajto T; Hostanska K; Weber K; Zinke H; Fischer J; Mengs U; Lentzen H; Saller R
    Nat Immun; 1998; 16(1):34-46. PubMed ID: 9789123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of human NK and LAK cytotoxicity against HCMV-infected cells by rhamnogalacturonan: specificity of reaction.
    Steinmassl M; Anderer FA
    Viral Immunol; 1996; 9(1):27-34. PubMed ID: 8733917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipopolysaccharide stimulates the proliferation of human CD56+CD3- NK cells: a regulatory role of monocytes and IL-10.
    Goodier MR; Londei M
    J Immunol; 2000 Jul; 165(1):139-47. PubMed ID: 10861046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant interferons or interleukin-2 increase cytotoxicity by human monocytes and NK cells.
    Frey JR; Kamber M; Peck R
    Lymphokine Res; 1987; 6(3):215-27. PubMed ID: 3114569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Viscum album oligosaccharide activating human natural cytotoxicity is an interferon gamma inducer.
    Mueller EA; Anderer FA
    Cancer Immunol Immunother; 1990; 32(4):221-7. PubMed ID: 2124513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
    Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H
    Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The CySF-L2 factor from dialysable human leucocyte extract activates natural killer cytotoxicity by induction of interferon gamma.
    Doelker I; Anderer FA
    Cancer Immunol Immunother; 1992; 34(5):299-305. PubMed ID: 1540976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of human T cells with NK cell markers by staphylococcal enterotoxin A via IL-12 but not via IL-18.
    Ami K; Ohkawa T; Koike Y; Sato K; Habu Y; Iwai T; Seki S; Hiraide H
    Clin Exp Immunol; 2002 Jun; 128(3):453-9. PubMed ID: 12109440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of human peripheral blood mononuclear cells with anti-CD3 monoclonal antibody vs IL2: disparate effects on T cell-dependent B cell differentiation despite similar effects on generation of unrestricted cytolytic activity.
    Stohl W; Elliott JE
    Clin Immunol Immunopathol; 1992 Oct; 65(1):30-8. PubMed ID: 1395122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical specificity of effector cell/tumor cell bridging by a Viscum album rhamnogalacturonan enhancing cytotoxicity of human NK cells.
    Mueller EA; Anderer FA
    Immunopharmacology; 1990; 19(1):69-77. PubMed ID: 2407685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expansion of cytotoxic CD3+ CD56+ cells from peripheral blood progenitor cells of patients undergoing autologous hematopoietic cell transplantation.
    Alvarnas JC; Linn YC; Hope EG; Negrin RS
    Biol Blood Marrow Transplant; 2001; 7(4):216-22. PubMed ID: 11349808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signal requirement for induction of MHC-unrestricted antitumor cytotoxicity of human T cell CD4+/CD8+ subpopulations.
    Zhu HG; Klein-Franke A; Anderer FA
    Anticancer Res; 1994; 14(3A):953-61. PubMed ID: 8074498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two pathways of exocytosis of cytoplasmic granule contents and target cell killing by cytokine-induced CD3+ CD56+ killer cells.
    Mehta BA; Schmidt-Wolf IG; Weissman IL; Negrin RS
    Blood; 1995 Nov; 86(9):3493-9. PubMed ID: 7579455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies to adhesion molecules inhibit the lytic function of MHC-unrestricted cytotoxic cells by preventing their activation.
    Zarcone D; Viale O; Cerruti G; Tenca C; Malorni W; Arancia G; Iosi F; Galandrini R; Velardi A; Moretta A
    Cell Immunol; 1992 Sep; 143(2):389-404. PubMed ID: 1380897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic activation of human natural killer cell cytotoxicity by histamine and interleukin-2.
    Hellstrand K; Hermodsson S
    Int Arch Allergy Appl Immunol; 1990; 92(4):379-89. PubMed ID: 2150668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Definition of a natural killer NKR-P1A+/CD56-/CD16- functionally immature human NK cell subset that differentiates in vitro in the presence of interleukin 12.
    Bennett IM; Zatsepina O; Zamai L; Azzoni L; Mikheeva T; Perussia B
    J Exp Med; 1996 Nov; 184(5):1845-56. PubMed ID: 8920872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High lytic activity against human leukemia cells after activation of allogeneic NK cells by IL-12 and IL-2.
    Uharek L; Zeis M; Glass B; Steinmann J; Dreger P; Gassmann W; Schmitz N; Müller-Ruchholtz W
    Leukemia; 1996 Nov; 10(11):1758-64. PubMed ID: 8892679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.